Wen-Jun Chai

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets

Yue Gong, Peng Ji, Yun‐Song Yang et al. · Cell Metabolism · 2020 · 491 citations · Full text

Medicine, Cancer Biology, Oncology +12

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial

Song‐Yang Wu, Ying Xu, Li Chen et al. · Molecular Cancer · 2022 · 97 citations · Full text

Life Sciences, Immunology, Oncology +17

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Li Chen, Yi‐Zhou Jiang, Song‐Yang Wu et al. · Clinical Cancer Research · 2022 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

In vivo multidimensional CRISPR screens identify <i>Lgals2</i> as an immunotherapy target in triple-negative breast cancer

Peng Ji, Yue Gong, Ming‐Liang Jin et al. · Science Advances · 2022 · 84 citations · Full text

Medicine, Immunology, Oncology +17

Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial

Songyang Wu, Xi Jin, Yin Liu et al. · Nature Medicine · 2025 · 30 citations

Medicine, Immunology, Oncology +15